Brett Richard Loman

Brett Richard Loman serves as Assistant Professor in both Animal Sciences and Nutritional Sciences at the University of Illinois at Urbana-Champaign, with additional affiliation at the Carl R. Woese Institute for Genomic Biology. His research integrates microbiome science with clinical applications, particularly focusing on gastrointestinal health in cancer therapy contexts.

Dr. Loman's primary research interests center on gut microbiome dynamics and their relationship to disease states. His work investigates how microbial communities influence chemotherapy-induced gastrointestinal symptoms, colorectal cancer development in inflammatory conditions, and potential nutritional interventions. Key areas include metaproteomic analysis of fecal microbiomes, dysbiosis in colitis models, and microbiome-based prediction of treatment side effects.

Recent publication trends reveal strong emphasis on translational microbiome research, with particular focus on chemotherapy patients and cancer-related gastrointestinal disorders. His 2024-2025 publications demonstrate methodological innovation in microbiome analysis while addressing clinically significant questions about symptom prediction and management.

Dr. Loman actively collaborates with medical researchers including oncologists and immunologists, as evidenced by his co-authorship on breast cancer microbiome studies. His work has generated significant scientific attention, with multiple publications receiving substantial news coverage and social media engagement.

He maintains laboratory operations through the Carl R. Woese Institute for Genomic Biology, where his team develops advanced techniques for microbiome analysis while investigating connections between gut flora, inflammation, and disease progression. Current projects examine ovarian hormone interactions with gut microbiota in metabolic disease models.